GlassScriptPhysician profile
Richard H Becker
NPI 1407851025
$714.26
in general payments reported to CMS, 2019-2025
8 companies · $145 in 2025
The $145 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $138 · 2020: $99.15 · 2021: $125 · 2022: $15.93 · 2023: $191 · 2025: $145.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $336.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $335.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $145.00 | 2025 | Repatha |
| Janssen Pharmaceuticals, INC | $124.98 | 2021 | |
| Boston Scientific Corporation | $123.07 | 2019 | |
| Medtronic, INC. | $118.45 | 2023 | Cobalt Dr Mri Surescan |
| Brainsway USA INC | $82.44 | 2020 | |
| Philips North America LLC | $72.39 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $32.00 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $15.93 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Richard Becker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.